BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.
BiohacksAI is an evolving research platform. New compounds and evidence are added continuously.
B
MOLECULAR TARGETUniProt: P07332

FES

FES proto-oncogene, tyrosine kinase

31 compounds · BiohacksAI corpus v20260307-01

31
compounds
Compounds
31
Gene Symbol
FES
NCBI Gene
2242

Looking for compounds that interact with FES?

View all 31 compounds →
About FES

FES (FES proto-oncogene, tyrosine kinase) is a biological target studied in biomedical research. The BiohacksAI corpus identifies 31 compounds with documented interactions with this target, based on BindingDB assay data and PubMed literature.

View FES on UniProt →
Compounds Targeting FES (31)
1
Foretinib
4.34
confidence
2
Tozasertib
4.33
confidence
3
Ceritinib
4.19
confidence
4
Bosutinib
4.08
confidence
5
Bi 2536
4.01
confidence
6
Brigatinib
3.81
confidence
7
Pazopanib
3.69
confidence
8
Neratinib
3.66
confidence
9
Nintedanib
3.61
confidence
10
Pelitinib
3.50
confidence
11
Tae 684
3.43
confidence
12
Fedratinib
3.40
confidence
13
Rociletinib
3.18
confidence
14
Lestaurtinib
3.04
confidence
15
Danusertib
2.94
confidence
16
R 406
2.83
confidence
17
Hesperadin
2.77
confidence
18
Plx 4720
2.71
confidence
19
Kw 2449
2.64
confidence
20
Ast 487
2.56
confidence
21
Lorlatinib
2.48
confidence
22
Azd 7762
2.30
confidence
23
Bms 754807
2.30
confidence
24
Rebastinib
2.20
confidence
25
Asp 3026
2.08
confidence
26
Amg 900
2.08
confidence
27
Pf 03814735
1.79
confidence
28
Ucn 01
1.79
confidence
298
studies
0.69
confidence
299
studies
0.69
confidence
117
studies
0.69
confidence
Top 31 compounds by confidence score. Derived from BindingDB assay data.
Data Source
Corpusv20260307-01
SourceBindingDB · ChEMBL · PubMed

All data is computationally derived from published research. Not medical advice. Independent validation required.